Igawa T, Nakabayashi H, Takeda R, Kurata Y
Department of Internal Medicine II, School of Medicine, Kanazawa University, Japan.
Endocr J. 1996 Jun;43(3):299-306. doi: 10.1507/endocrj.43.299.
By an indirect immunofluorescence method with In-111 cells (hamster insulinoma cell line), circulating islet cell surface antibodies (ICSA) were detected in 7 (20%) out of 36 patients with non-insulin dependent diabetes mellitus (NIDDM), 9% of 68 chronic thyroiditis (CT) patients, or 16% of 19 NIDDM patients associated with CT, but not in 18 normal subjects. Sera from five out of nine ICSA-positive patients examined further also showed cell-surface immunofluorescence on TPC-1 cells (human thyroid papillary adenocarcinoma cell line), and prior absorption of the sera with In-111 cells abolished the immunofluorescence. The 64 kDa protein from In-111 cells or human thyroid follicular cells was immunoprecipitated with ICSA-positive sera. In one case of NIDDM associated with CT, 64 kDa protein was detected in both cells. The results indicate that some ICSA in NIDDM patients recognize the same or a very closely-related autoantigen(s) in both islet beta-cells and thyroid follicular cells, suggesting an explanation, at least in part, for the autoimmune mechanism(s) in clinical association of NIDDM and CT.
采用针对In - 111细胞(仓鼠胰岛素瘤细胞系)的间接免疫荧光法,在36例非胰岛素依赖型糖尿病(NIDDM)患者中的7例(20%)、68例慢性甲状腺炎(CT)患者中的6例(9%)或19例合并CT的NIDDM患者中的3例(16%)检测到循环胰岛细胞表面抗体(ICSA),而在18名正常受试者中未检测到。进一步检测的9例ICSA阳性患者中有5例的血清在TPC - 1细胞(人甲状腺乳头状腺癌细胞系)上也显示出细胞表面免疫荧光,并且用In - 111细胞预先吸收血清可消除免疫荧光。用ICSA阳性血清对In - 111细胞或人甲状腺滤泡细胞的64 kDa蛋白进行免疫沉淀。在1例合并CT的NIDDM患者中,在两种细胞中均检测到64 kDa蛋白。结果表明,NIDDM患者中的一些ICSA识别胰岛β细胞和甲状腺滤泡细胞中相同或非常密切相关的自身抗原,这至少部分解释了NIDDM与CT临床关联中的自身免疫机制。